QDEL - Quidel Corporation
NASDAQ
->
Healthcare
->
Diagnostics & Research
San Diego,
United States
Type: Equity
QDEL price evolution
QDEL
| (in millions $) | 29 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $107 | $78.5 | $118.9 | |
| Short term investments | $48.4 | |||
| Net receivables | $541.7 | $269.5 | $271.7 | $303.3 |
| Inventory | $577 | $602 | $583.1 | $577.8 |
| Total current assets | $1412.6 | $1341.3 | $1212.4 | $1310.5 |
| Long term investments | $7.4 | |||
| Property, plant & equipment | $1539.2 | $1503.9 | $1621.8 | $1613.4 |
| Goodwill & intangible assets | $3568.5 | $3622.1 | $5426.3 | |
| Total noncurrent assets | $5347.9 | $5490.9 | $7252.6 | |
| Total investments | $55.8 | |||
| Total assets | $6801.1 | $6689.2 | $6703.3 | $8563.1 |
| Current liabilities | ||||
| Accounts payable | $247.2 | $237.4 | $249.6 | $294.8 |
| Deferred revenue | ||||
| Short long term debt | $356.4 | $161.1 | $139.8 | |
| Total current liabilities | $1027.3 | $932.4 | $779.8 | $1006.6 |
| Long term debt | $2176.6 | $2384.9 | $2422.8 | $2274.8 |
| Total noncurrent liabilities | $2583.3 | $2615.8 | $2723.4 | |
| Total debt | $2741.3 | $2583.9 | $2587.4 | |
| Total liabilities | $3614.4 | $3515.7 | $3395.6 | $3557.2 |
| Shareholders' equity | ||||
| Retained earnings | $314.2 | $334.1 | $481.8 | $2187.8 |
| Other shareholder equity | -$3.5 | -$24.6 | -$26.2 | $5005.9 |
| Total shareholder equity | $3173.5 | $3307.7 | $5005.9 | |
| (in millions $) | 31 Jan 2024 | 1 Feb 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $118.9 | $292.9 | $802.75 | $489.94 |
| Short term investments | $48.4 | $52.1 | $25.76 | |
| Net receivables | $303.3 | $542.1 | $377.97 | $497.69 |
| Inventory | $577.8 | $524.1 | $198.76 | $113.8 |
| Total current assets | $1310.5 | $1575.1 | $1440.31 | $1142.4 |
| Long term investments | $7.4 | $21 | $37.85 | |
| Property, plant & equipment | $1613.4 | $1520 | $476.82 | $211.03 |
| Goodwill & intangible assets | $5426.3 | $5600.6 | $435.68 | $459.46 |
| Total noncurrent assets | $7252.6 | $7280.7 | $990.06 | $728.76 |
| Total investments | $55.8 | $73.1 | $63.61 | |
| Total assets | $8563.1 | $8855.8 | $2430.37 | $1871.16 |
| Current liabilities | ||||
| Accounts payable | $294.8 | $283.3 | $101.49 | $86.32 |
| Deferred revenue | ||||
| Short long term debt | $139.8 | $207.5 | $10.04 | $7.8 |
| Total current liabilities | $1006.6 | $1007 | $323.52 | $336.96 |
| Long term debt | $2274.8 | $2430.8 | $128.56 | $100.71 |
| Total noncurrent liabilities | $2723.4 | $2914.2 | $177.49 | $201.5 |
| Total debt | $2587.4 | $2824.7 | $138.59 | $108.5 |
| Total liabilities | $3557.2 | $3921.2 | $501.01 | $538.46 |
| Shareholders' equity | ||||
| Retained earnings | $2187.8 | $2197.9 | $1649.2 | $944.97 |
| Other shareholder equity | $5005.9 | $2.13 | $0.35 | -$0.43 |
| Total shareholder equity | $5005.9 | $4934.6 | $1929.36 | $1332.7 |
| (in millions $) | 29 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $727.1 | $637 | $711 | $742.6 |
| Cost of revenue | $361 | $378.9 | ||
| Gross Profit | $352.3 | $276 | $332.1 | $381.3 |
| Operating activities | ||||
| Research & development | $56.3 | $59.2 | ||
| Selling, general & administrative | $188.2 | $204.7 | ||
| Total operating expenses | $300.5 | $393.5 | $2090.1 | $308.2 |
| Operating income | -$117.5 | -$1758 | ||
| Income from continuing operations | ||||
| EBIT | -$121.9 | -$1759.9 | ||
| Income tax expense | -$8.9 | -$15.2 | -$92.9 | -$16.2 |
| Interest expense | -$42.9 | $41 | $39 | -$36.7 |
| Net income | ||||
| Net income | -$19.9 | -$147.7 | -$1706 | $7 |
| Income (for common shares) | -$147.7 | -$1706 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2997.8 | $3266 | $1698.55 | $1661.67 |
| Cost of revenue | $1330 | $427.66 | $312.81 | |
| Gross Profit | $1494.4 | $1936 | $1270.89 | $1348.86 |
| Operating activities | ||||
| Research & development | $190.5 | $95.7 | $84.29 | |
| Selling, general & administrative | $621 | $259.57 | $200.54 | |
| Total operating expenses | $1241.9 | $1092.3 | $364.83 | $288.53 |
| Operating income | $843.7 | $906.07 | $1060.33 | |
| Income from continuing operations | ||||
| EBIT | $811.6 | $906.07 | $1049.94 | |
| Income tax expense | -$19 | $187.2 | $196.13 | $230.03 |
| Interest expense | -$147.6 | $75.7 | $5.71 | $9.62 |
| Net income | ||||
| Net income | -$10.1 | $548.7 | $704.23 | $810.29 |
| Income (for common shares) | $548.7 | $704.23 | $810.29 | |
| (in millions $) | 29 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$147.7 | -$1706 | $7 | |
| Operating activities | ||||
| Depreciation | $116.1 | $114.9 | $115.4 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11.2 | $9 | $12.3 | |
| Total cash flows from operations | -$97.9 | -$0.7 | $80.4 | |
| Investing activities | ||||
| Capital expenditures | -$35.3 | -$66.1 | -$45.6 | |
| Investments | $55.9 | $0.5 | ||
| Total cash flows from investing | -$112 | -$35.3 | -$20.2 | -$55.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.1 | $0.5 | -$3.7 | |
| Net borrowings | $160.9 | -$13.2 | -$53.6 | |
| Total cash flows from financing | $117.7 | $162.5 | -$18.5 | -$57.8 |
| Effect of exchange rate | -$0.5 | -$0.8 | -$1.1 | $2.1 |
| Change in cash and equivalents | $24.5 | $28.5 | -$40.5 | -$30.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$10.1 | $548.7 | $704.23 | $810.29 |
| Operating activities | ||||
| Depreciation | $457.2 | $283.6 | $54.38 | $49.09 |
| Business acquisitions & disposals | -$1511.4 | |||
| Stock-based compensation | $51.6 | $48.4 | $25.41 | $21.02 |
| Total cash flows from operations | $280.2 | $885.3 | $805.87 | $629.76 |
| Investing activities | ||||
| Capital expenditures | -$195.8 | -$122.5 | -$255.84 | -$63.32 |
| Investments | $18.2 | -$10.3 | -$63.69 | |
| Total cash flows from investing | -$187.6 | -$1644.2 | -$319.53 | -$63.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.4 | -$47.9 | -$95.89 | -$38.28 |
| Net borrowings | -$226.4 | $346.2 | -$0.26 | -$43.96 |
| Total cash flows from financing | -$265.8 | $252 | -$173.18 | -$130.28 |
| Effect of exchange rate | -$1.2 | -$2 | -$0.35 | $1 |
| Change in cash and equivalents | -$174.4 | -$508.9 | $312.81 | $437.17 |
News
Fundamentals
| Market cap | $2.92B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 67.20M |
| Revenue | $2.82B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$1.87B |
| Revenue Q/Q | 9.32% |
| Revenue Y/Y | -10.87% |
| P/E ratio | -1.56 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.04 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$27.78 |
|---|---|
| ROA | -25.96% |
| ROE | N/A |
| Debt/Equity | 0.71 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.38 |
| Quick ratio | 0.81 |